Measurement of the novel antitumor agent 17-(allylamino)-17-demethoxygeldanamycin in human plasma by high-performance liquid chromatography
- 1 May 2001
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 755 (1-2) , 237-243
- https://doi.org/10.1016/s0378-4347(01)00113-x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycinCancer Chemotherapy and Pharmacology, 1998
- Preclinical pharmacologic evaluation of geldanamycin as an antitumor agentCancer Chemotherapy and Pharmacology, 1995
- Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.Proceedings of the National Academy of Sciences, 1994
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Effects of herbimycin derivatives on src oncogene function in relation to antitumor activity.The Journal of Antibiotics, 1988
- GELDANAMYCIN, A NEW ANTIBIOTICThe Journal of Antibiotics, 1970